PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

September 4, 2023

Study Completion Date

September 4, 2024

Conditions
Carcinoma, Hepatocellular
Interventions
DIAGNOSTIC_TEST

PET MRI with PSMA

A whole-body PET using PSMA as a radiotracer associated to an upper abdomen MRI with gadoxetic acid as contrast agent

Trial Locations (1)

01246-903

RECRUITING

University of Sao Paulo, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

University of Sao Paulo

OTHER

NCT05580835 - PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter